Cedar Bridge
PE
2010
$140 M
Dubai, Dubai, United Arab Emirates
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
CedarBridge is a middle market private equity firm founded in 2011, with headquarters in Dubai, United Arab Emirates. The firm was co-founded by Magellan Makhlouf and Imad Ghandour, both serving as Managing Directors. CedarBridge's team includes experienced professionals with backgrounds in investment and operational management, focusing on innovative strategies tailored to the MENA and European markets.
CedarBridge invests in sectors such as healthcare, retail, education, beauty, and food & beverage, with a focus on the MENA region and Europe. The firm typically invests between $1 to $10 million in equity, targeting companies with enterprise values ranging from $2 to $30 million. CedarBridge manages several funds, including CedarBridge High Growth I and II, and is currently fundraising for CedarBridge High Growth III. The firm has over $150 million in assets under management.
Notable investments by CedarBridge include Advanced Laboratory Services - a healthcare provider, Kids First Group - an education service provider, and Dreamworks Spa - a wellness and beauty service. The firm has a track record of successful exits, including companies like Al Shams Laboratories and The Grooming Company.
Industry
Region of investment
Cedar Bridge Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
CedarBridge High Growth I
|
Private Equity (PE)
|
Consumer Products
Healthcare Services
Retail
Education
Food and Beverage
Edtech
Financial Services
Fintech
Foodtech
Medical Devices
Other
Pharmaceuticals
MedTech
Life Sciences
Infrastructure
HealthTech
|
Series B
|
Middle East
Africa
Europe
|
$1-5 m
|
—
|
January 2011
|
|
CedarBridge High Growth II
|
Private Equity (PE)
|
Consumer Products
Healthcare Services
Retail
Education
Food and Beverage
Edtech
Financial Services
Fintech
Foodtech
Medical Devices
Other
Pharmaceuticals
MedTech
Life Sciences
Infrastructure
HealthTech
|
Series B
|
Middle East
Africa
Europe
|
$1-5 m
|
—
|
January 2015
|
|
CedarBridge High Growth III
|
Private Equity (PE)
|
Consumer Products
Healthcare Services
Retail
Education
Food and Beverage
Edtech
Financial Services
Fintech
Foodtech
Medical Devices
Other
Pharmaceuticals
MedTech
Life Sciences
Infrastructure
HealthTech
|
Series B
|
Middle East
Africa
Europe
|
$1-5 m
|
—
|
July 2026
|
